Skip to main content
. 2018 Mar 16;17:54. doi: 10.1186/s12944-018-0703-y

Table 4.

Association between total phytosterols intake and prevalence of overweight/obesity

Overall Q1 Q2 Q3 Q4
 Participants, n 228 228 228 228
 No. of cases, n 100 90 82 74
 Intake, mg/d 161.9 231.3 294 383
Crude 1 0.835 (0.575, 1.212) 0.719 (0.493, 1.047) 0.615 (0.420, 0.900)*
 Model 1 1 0.746 (0.496, 1.122) 0.762 (0.504, 1.151) 0.496 (0.324, 0.761)**
 Model 2 1 0.708 (0.462, 1.085) 0.711 (0.445, 1.136) 0.440 (0.254, 0.763)**
Men Q1 Q2 Q3 Q4
 Participants, n 102 102 102 103
 No. of cases, n 49 44 34 32
 Intake, mg/d 157.3 233 381.4 301
 Crude 1 0.835 (0.480, 1.451) 0.541 (0.307, 0.952)* 0.481 (0.272, 0.850)*
 Model 1 1 0.752 (0.412, 1.373) 0.552 (0.294, 1.035) 0.509 (0.274, 0.946)*
 Model 2 1 0.778 (0.403, 1.501) 0.559 (0.244, 1.183) 0.487 (0.234, 0.918)*
Women Q1 Q2 Q3 Q4
 Participants, n 125 126 126 126
 No. of cases, n 52 51 42 42
 Intake, mg/d 165.6 229.3 287.6 384.2
 Crude 0.955 (0.577, 1.579) 0.702 (0.420, 1.173) 0.702 (0.420, 1.173)
 Model 1 0.927 (0.527, 1.631) 0.790 (0.441, 1.414) 0.501 (0.275, 0.911)*
 Model 2 1 0.758 (0.416, 1.380) 0.537 (0.275, 1.048) 0.277 (0.124, 0.619)**

Model 1: adjusting for age, education, income, PAL, exercise status, smoking and drinking habits

Model 2: Model 1 + dietary carbohydrate, fat, protein, fiber and cholesterol intake were adjusted

* P < 0.05; ** P < 0.01 compared with the 1st quartile